KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Non-Current Debt (2022 - 2025)

Opko Health (OPK) has disclosed Non-Current Debt for 4 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Non-Current Debt fell 99.08% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Dec 2025, down 99.08%, and an annual FY2025 reading of $2.3 million, down 99.08% over the prior year.
  • Non-Current Debt was $2.3 million for Q4 2025 at Opko Health, down from $2.5 million in the prior quarter.
  • Across five years, Non-Current Debt topped out at $245.8 million in Q1 2025 and bottomed at $2.3 million in Q4 2025.
  • Average Non-Current Debt over 4 years is $45.3 million, with a median of $5.9 million recorded in 2023.
  • Peak annual rise in Non-Current Debt hit 5990.04% in 2025, while the deepest fall reached 99.08% in 2025.
  • Year by year, Non-Current Debt stood at $9.1 million in 2022, then fell by 15.27% to $7.7 million in 2023, then soared by 3085.58% to $245.6 million in 2024, then tumbled by 99.08% to $2.3 million in 2025.
  • Business Quant data shows Non-Current Debt for OPK at $2.3 million in Q4 2025, $2.5 million in Q3 2025, and $2.8 million in Q2 2025.